The CSL Research Acceleration Initiative supports research organisations and companies worldwide in partnering with CSL on research that aims to accelerate the discovery of innovative biotherapies.
Funder: CSL Behring
Due Dates (Anticipated): January 2027 (Application deadline)
Funding Amounts: Not stated
Summary: The initiative connects CSL with research organisations and companies worldwide to accelerate discovery of innovative biotherapies.
CSL’s Research Acceleration Initiative aims to fast-track the discovery of innovative biotherapies through partnerships with research organisations and companies around the world. It brings external research together with CSL to accelerate discovery.